2 results
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... oral route by using ... Patients should ... been shown non-inferior ... #Diabetes #Pharmacology
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
isolate DST result should ... Tuberculosis #MDRTB #management ... #Treatment #antimicrobials ... #regimens #pharmacology ... #dosing #idsa #